- Developed go-to-market business plan with executive leadership for marketing concierge services- Identified and consulted on new business opportunities to increase sales growth - Facilitated c-suite strategic business partnerships to increase engagement opportunities

Recruited to lead the strategy in the Southwest US driving sales in top community and NCI cancer centers, academic and IDN Oncology Service Line segments, and hospital networks worth $25m in revenue. Led Brand Market Access, Precision Medicine Solutions, and Next Generation Testing portfolio in different growth phases. Grew gross sales by 23% YoY.- Developed and implemented overall key account strategies and engagement approaches, strategic, and tactical development, and account deployment to maximize market access and opportunities with C-suites in large oncology centers of excellence, institutions, and networks in the Southwest US markets with 40% increased growth in 2022. - Drove innovative go-to-market strategies with Area Vice Presidents and Regional Business Directors through strategic planning within key accounts and department chairs: precision medicine, population health decision-makers, medical oncology, pathology services, EMR integration, and online data platforms. - Leveraged and connected national KOL population health leaders on business opportunity engagements with organizations and advocacy groups. - Led the customer-facing teams and aligned business partners in the development and deployment of multidisciplinary account-specific business plans. Utilized customer and market insights to identify opportunities, threats, and potential gaps. - Led within a cross-functional and matrix environment (sales, medical, patient services, marketing, managed markets, etc.) to secure data, resources, and support key sales initiatives which included population health.

Supported franchise operations and activities by acting as the primary liaison between the regional field team and other Genentech home office departments. Co-lead business planning development, calibration process, and additional leadership initiatives for six divisions across the West Sales Region. Implemented national strategies into regional customer-centric opportunities resulting in optimal customer experience, team dynamics, and regional performance.- Applied critical thinking, data analysis, leadership and communication skills to spearhead field engagement and the achievement of $2.2B in 22 state regional sales in this developmental role - Created regional business plans synthesizing brand strategy and marketing priorities with regional data analysis resulting in YOY sales excellence for 3 consecutive years - Motivated a cross-functional team leveraging strong collaborative relationships with sales, marketing, and thought leader services to develop and execute strategic speaker services- Developed strong relationships and account management plans with C-suites in key accounts. - Leveraged networks and relationships in the healthcare ecosystem by co-creating solutions with customers. Implemented employee engagement workshop for over 200+ Henry Ford Health Systems employees and Oncology Consultants employees

Interim District Manager Led a team of clinical oncology specialists representing the HER2, Triple Negative Breast Cancer, and Antibody Drug Conjugate product portfolio. Responsible for division sales goals, coaching sales specialists, leadership and development mentoring, and various company leadership roles (i.e. Genentech Women's Professionals, Breast Cancer Marathon Exec. Chair, and other cultural initiatives).- Engaged direct reports in a culture of development and accountability to achieve exceptional performance for a $280M Breast cancer targeted therapy portfolio in a high-profile influential marketplace. - Empowered a high-functioning team to balance a multi-product portfolio with new product launches, resulting in over 12% YOY sales growth and top-tier performance- Collaborated with cross-functional and enterprise partners to identify opportunities and lead teams through impactful Breast franchise initiatives- Coached reps on novel resources and processes to support key accounts, enabling them to build a stronger relationship and better meet and exceed their goals.

Launched the first biologic therapies in the oncology market for breast, colon, gastric, lung, non-Hodgkins lymphoma, and pancreatic cancers. Provided in-services and educational programs for oncologists, surgeons, pathologists, pharmacists, nurses, hospitals, and breast cancer advocates. Identified and developed national speakers and advocates from assigned territories. Ensure coverage and reimbursement with practice managers and implement fellowship initiatives.- Successfully launched 7 products and 12 indications in the Genentech BioOncology franchise; including Rituxan, Herceptin, Avastin, Tecentriq, Tarceva, Perjeta, and Kadcyla.- National Herceptin Representative of the Year 2010- Served as Interim DM

Negotiated contracting for management network and ancillary contracts to managed care entities. Implemented and trained IPAs and managed care personnel on clinical outcomes /data.